OpenURL Connection Search

Select item for more details and to access through your institution.

Letter to the Editor: "18F-FDOPA PET for the Noninvasive Prediction of Glioma Molecular Parameters: A Radiomics Study".
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.122.263837
By:
- Langen, Karl-Josef;
- Mottaghy, Felix M.
Publication type:
Article
The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer - Going Beneath the Surface with Molecular Imaging.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263684
By:
- Sutera, Philip;
- Phillips, Ryan M.;
- Deek, Matthew;
- Ozyigit, Gokhan;
- Onal, Cem;
- Tran, Phuoc T.
Publication type:
Article
DOE and HHS Certify Sufficient 99 Mo Supplies.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 26N
Publication type:
Article
Tumor sink effect in 68Ga-PSMA-11 PET: Myth or Reality?
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.122.263802
By:
- Privé, Bastiaan M.;
- Peters, Steffie M. B.;
- Uijen, Maike J. M.;
- Janssen, Marcel J. R.;
- van Gemert, Willemijn A. M.;
- Kreissl, Michael C.;
- Ezzidin, Samer;
- Konijnenberg, Mark W.;
- Nagarajah, James
Publication type:
Article
Reply to 'Adding non-tumor radiomic features to the prognostic model is bothersome but useful'.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263730
By:
- Yusufaly, Tahir I.;
- Mell, Loren K.
Publication type:
Article
FDA Approves New 68Ga Kit for Prostate Cancer PET.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 26N
Publication type:
Article
Why We Did What We Did: PSMA-PET/CT Selection Criteria for the VISION Trial.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263638
By:
- Kuo, Phillip H.;
- Benson, Taylor;
- Messmann, Richard;
- Groaning, Michael
Publication type:
Article
18F-FDG Fetal Dosimetry Calculated with PET/MRI.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263561
By:
- Zanotti-Fregonara, Paolo;
- Tatsuya Ishiguro;
- Kosuke Yoshihara;
- Shiro Ishii;
- Takayuki Enomoto
Publication type:
Article
First-in-human evaluation of 18F-SMBT-1, a novel 18F-labeled MAO-B PET tracer for imaging reactive astrogliosis.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263254
By:
- Villemagne, Victor L.;
- Harada, Ryuichi;
- Doré, Vincent;
- Shozo Furumoto;
- Mulligan, Rachel;
- Yukitsuka Kudo;
- Burnham, Samantha;
- Krishnadas, Natasha;
- Bozinovski, Svetlana;
- Kun Huang;
- Lopresti, Brian J.;
- Kazuhiko Yanai;
- Rowe, Christopher C.;
- Nobuyuki Okamura
Publication type:
Article
Targeted Alpha-Emitter Therapy With 212Pb-DOTAMTATE for the Treatment of Metastatic SSTR-Expressing Neuroendocrine Tumors: First-in-Human, Dose-Escalation Clinical Trial.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263230
By:
- Delpassand, Ebrahim S.;
- Tworowska, Izabela;
- Esfandiari, Rouzbeh;
- Torgue, Julien;
- Hurt, Jason;
- Shafie, Afshin;
- Núñez, Rodolfo
Publication type:
Article
Administration Routes for SSTR- / PSMA- and FAP-directed Theranostic Radioligands in Mice.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263453
By:
- Klose, Jasmin M.;
- Wosniack, Jasmin;
- Iking, Janette;
- Staniszewska, Magdalena;
- Zarrad, Fadi;
- Trajkovic-Arsic, Marija;
- Herrmann, Ken;
- Costa, Pedro Fragoso;
- Lueckerath, Katharina;
- Fendler, Wolfgang P.
Publication type:
Article
Utility of 18F-rhPSMA-7.3 positron emission tomography for imaging of primary prostate cancer and pre-operative efficacy in N-staging of unfavorable intermediate to very high-risk patients validated by histopathology.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263440
By:
- Langbein, Thomas;
- Hui Wang;
- Rauscher, Isabel;
- Kroenke, Markus;
- Knorr, Karina;
- Wurzer, Alexander;
- Schwamborn, Kristina;
- Maurer, Tobias;
- Horn, Thomas;
- Haller, Bernhard;
- Wester, Hans-Jürgen;
- Eiber, Matthias
Publication type:
Article
The change in management by 18F-DCFPyL PSMA PET scanning in patients undergoing post-prostatectomy radiotherapy, with early biochemical response outcomes.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263521
By:
- Ng, Michael;
- Guerrieri, Mario;
- Lih Ming Wong;
- Taubman, Kim;
- Sutherland, Tom;
- Benson, Angela;
- Byrne, Graeme;
- Koschel, Sam;
- Yap, Kelvin;
- Starmans, Michelle;
- Ong, Grace;
- Macleod, Craig;
- Foo, Marcus;
- Chao, Michael
Publication type:
Article
SV2A PET imaging is a non-invasive marker for the detection of spinal damages in experimental models of spinal cord injury.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263222
By:
- Bertoglio, Daniele;
- Halloin, Nicolas;
- De Lombaerde, Stef;
- Jankovski, Aleksandar;
- Verhaeghe, Jeroen;
- Nicaise, Charles;
- Staelens, Steven
Publication type:
Article
Proceedings: PET Drugs: A Workshop on Inspections Management and Regulatory Considerations.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263443
By:
- Bunning, Sue;
- Ignace, Christopher;
- Mattmuller, Steve;
- Schwarz, Sally W.;
- Scott, Peter J. H.;
- VanBrocklin, Henry F.;
- Zigler, Steven S.
Publication type:
Article
Analysis of short term and stable DNA damage in patients with differentiated thyroid cancer treated with 131I in hypothyroidism or with rhTSH for remnant ablation.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263442
By:
- Signore, Alberto;
- Campagna, Giuseppe;
- Marinaccio, Jessica;
- de Vitis, Marco;
- Lauri, Chiara;
- Berardinelli, Francesco;
- Tofani, Anna;
- Chianelli, Marco;
- Borro, Marina;
- Gentile, Giovanna;
- Simmaco, Maurizio;
- Colombini, Francesco;
- Giovanetti, Anna;
- Sgura, Antonella
Publication type:
Article
Substitution of L-Trp by α-methyl-L-Trp in 177Lu-RM2 results in 177Lu-AMTG, a high affinity GRPR ligand with improved in vivo stability.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263323
By:
- Günther, Thomas;
- Deiser, Sandra;
- Felber, Veronika;
- Beck, Roswitha;
- Wester, Hans-Jürgen
Publication type:
Article
Synthesis and Preclinical Evaluation of 177Lu-labeled Radiohybrid PSMA Ligands (rhPSMAs) for Endoradiotherapy of Prostate Cancer.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263371
By:
- Wurzer, Alexander;
- Kunert, Jan-Philip;
- Fischer, Sebastian;
- Felber, Veronika;
- Beck, Roswitha;
- de Rose, Francesco;
- D'Alessandria, Calogero;
- Weber, Wolfgang;
- Wester, Hans-Jürgen
Publication type:
Article
Interrogating glioma-associated microglia/macrophage dynamics under CSF-1R therapy with multi-tracer in vivo PET/MR imaging.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263318
By:
- Foray, Claudia;
- Barca, Cristina;
- Winkeler, Alexandra;
- Wagner, Stefan;
- Hermann, Sven;
- Schäfers, Michael;
- Grauer, Oliver M.;
- Zinnhardt, Bastian;
- Jacobs, Andreas H.
Publication type:
Article
Evaluation of Data-Driven Rigid Motion Correction in Clinical Brain PET Imaging.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263309
By:
- Spangler-Bickell, Matthew G.;
- Hurley, Samuel A.;
- Pirasteh, Ali;
- Perlman, Scott B.;
- Deller, Timothy;
- McMillan, Alan B.
Publication type:
Article
In vivo evaluation of six analogs of 11C-ER176 as candidate 18F-labeled radioligands for translocator protein 18 kDa (TSPO).
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263168
By:
- Jae-Hoon Lee;
- Siméon, Fabrice G.;
- Jeih-San Liow;
- Morse, Cheryl L.;
- Gladding, Robert L.;
- Santamaria, Jose A. Montero;
- Henter, Ioline D.;
- Zoghbi, Sami S.;
- Pike, Victor W.;
- Innis, Robert B.
Publication type:
Article
Positron emission tomography imaging of system xC¯ in immune cells for assessment of disease activity in mice and patients with inflammatory bowel disease.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263289
By:
- Minjung Seo;
- Yeji Kim;
- Byong Duk Ye;
- Sang Hyoung Park;
- Seog-Young Kim;
- Jin Hwa Jung;
- Sung Wook Hwang;
- Sun Young Chae;
- Dong Yun Lee;
- Sang Ju Lee;
- Seung Jun Oh;
- Jihun Kim;
- Ji Young Kim;
- Sae Jung Na;
- Misung Kim;
- Sang-Yeob Kim;
- Koglin, Norman;
- Stephens, Andrew W.;
- Mi-Na Kweon;
- Dae Hyuk Moon
Publication type:
Article
Assessing reactive astrogliosis with 18F-SMBT-1 across the Alzheimer's disease spectrum.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263255
By:
- Villemagne, Victor L.;
- Ryuichi Harada;
- Doré, Vincent;
- Shozo Furumoto;
- Mulligan, Rachel;
- Yukitsuka Kudo;
- Burnham, Samantha;
- Krishnadas, Natasha;
- Bourgeat, Pierrick;
- Ying Xia;
- Laws, Simon;
- Bozinovski, Svetlana;
- Kun Huang;
- Ikonomovic, Milos D.;
- Fripp, Jürgen;
- Kazuhiko Yanai;
- Nobuyuki Okamura;
- Rowe, Christopher C.
Publication type:
Article
18F-PFPN PET: a new and attractive imaging modality for patients with malignant melanoma.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263179
By:
- Xiao Zhang;
- Mengting Li;
- Yongkang Gai;
- Jing Chen;
- Juan Tao;
- Liu Yang;
- Fan Hu;
- Wenyu Song;
- Tzu-Chen Yen;
- Xiaoli Lan
Publication type:
Article
Molecular imaging of Neuroendocrine Prostate Cancer by targeting Delta-like Ligand 3.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263221
By:
- Korsen, Joshua A.;
- Kalidindi, Teja M.;
- Khitrov, Samantha;
- Samuels, Zachary V.;
- Chakraborty, Goutam;
- Gutierrez, Julia A.;
- Poirier, John T.;
- Rudin, Charles M.;
- Yu Chen;
- Morris, Michael J.;
- Pillarsetty, Naga Vara Kishore;
- Lewis, Jason S.
Publication type:
Article
Prospective phase II trial of prognostication by 68Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263177
By:
- Carlsen, Esben Andreas;
- Loft, Mathias;
- Loft, Annika;
- Berthelsen, Anne Kiil;
- Langer, Seppo W.;
- Knigge, Ulrich;
- Kjaer, Andreas
Publication type:
Article
The impact of semi-automatic segmentation methods on metabolic tumor volume, intensity and dissemination radiomics in 18F-FDG PET scans of patients with classical Hodgkin lymphoma.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263067
By:
- Driessen, Julia;
- Zwezerijnen, Gerben J. C.;
- Schöder, Heiko;
- Drees, Esther E. E.;
- Kersten, Marie José;
- Moskowitz, Alison J.;
- Moskowitz, Craig H.;
- Eertink, Jakoba J.;
- de Vet, Henrica C. W.;
- Hoekstra, Otto S.;
- Zijlstra, Josée M.;
- Boellaard, Ronald
Publication type:
Article
Short-term colony stimulating factor-1 receptor inhibition-induced repopulation after stroke assessed by longitudinal 18F-DPA-714 PET imaging.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263004
By:
- Barca, Cristina;
- Kiliaan, Amanda J.;
- Wachsmuth, Lydia;
- Foray, Claudia;
- Hermann, Sven;
- Faber, Cornelius;
- Schäfers, Michael;
- Wiesmann, Maximilian;
- Zinnhardt, Bastian;
- Jacobs, Andreas H.
Publication type:
Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.262884
By:
- Alberge, Jean-Baptiste;
- Kraeber-Bodéré, Françoise;
- Jamet, Bastien;
- Touzeau, Cyrille;
- Caillon, Hélène;
- Wuilleme, Soraya;
- Béné, Marie-Christine;
- Kampfenkel, Tobias;
- Sonneveld, Pieter;
- van Duin, Mark;
- Avet-Loiseau, Herve;
- Corre, Jill;
- Magrangeas, Florence;
- Carlier, Thomas;
- Bodet-Milin, Caroline;
- Chérel, Michel;
- Moreau, Philippe;
- Minvielle, Stéphane;
- Bailly, Clément
Publication type:
Article
SIR-Spheres® activity measurements reveal systematic miscalibration.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.262650
By:
- Graves, Stephen A.;
- Martin, Molly;
- Tiwari, Ashok;
- Merrick, Michael;
- Sunderland, John
Publication type:
Article
Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.262622
By:
- Westdorp, Harm;
- Verhoeff, Sarah R.;
- Gotthardt, Martin;
- van Herpen, Carla M. L.;
- van den Heuvel, Michel M.;
- Heskamp, Sandra;
- Aarntzen, Erik H. J. G.
Publication type:
Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of 89Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.262485
By:
- Farwell, Michael D.;
- Gamache, Raymond F.;
- Babazada, Hasan;
- Hellmann, Matthew D.;
- Harding, James J.;
- Korn, Ron;
- Mascioni, Alessandro;
- Le, William;
- Wilson, Ian;
- Gordon, Michael S.;
- Wu, Anna M.;
- Ulaner, Gary A.;
- Wolchok, Jedd D.;
- Postow, Michael A.;
- Pandit-Taskar, Neeta
Publication type:
Article
Fluorescent molecular imaging can improve intraoperative sentinel margin detection in oral squamous cell carcinoma.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.262235
By:
- Krishnan, Giri;
- van den Berg, Nynke S.;
- Naoki Nishio;
- Kapoor, Shrey;
- Pei, Jaqueline;
- Freeman, Laura;
- Yu-Jin Lee;
- van Keulen, Stan;
- Farkurnejad, Shayan;
- Condon, James;
- Baik, Fred M.;
- Martin, Brock A.;
- Rosenthal, Eben L.
Publication type:
Article

Found: 33

Letter to the Editor: "<sup>18</sup>F-FDOPA PET for the Noninvasive Prediction of Glioma Molecular Parameters: A Radiomics Study".

The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer - Going Beneath the Surface with Molecular Imaging.

DOE and HHS Certify Sufficient <sup>99</sup> Mo Supplies.

Tumor sink effect in <sup>68</sup>Ga-PSMA-11 PET: Myth or Reality?

Reply to 'Adding non-tumor radiomic features to the prognostic model is bothersome but useful'.

FDA Approves New<sup> 68</sup>Ga Kit for Prostate Cancer PET.

Why We Did What We Did: PSMA-PET/CT Selection Criteria for the VISION Trial.

<sup>18</sup>F-FDG Fetal Dosimetry Calculated with PET/MRI.

First-in-human evaluation of <sup>18</sup>F-SMBT-1, a novel <sup>18</sup>F-labeled MAO-B PET tracer for imaging reactive astrogliosis.

Targeted Alpha-Emitter Therapy With <sup>212</sup>Pb-DOTAMTATE for the Treatment of Metastatic SSTR-Expressing Neuroendocrine Tumors: First-in-Human, Dose-Escalation Clinical Trial.

Administration Routes for SSTR- / PSMA- and FAP-directed Theranostic Radioligands in Mice.

Utility of <sup>18</sup>F-rhPSMA-7.3 positron emission tomography for imaging of primary prostate cancer and pre-operative efficacy in N-staging of unfavorable intermediate to very high-risk patients validated by histopathology.

The change in management by <sup>18</sup>F-DCFPyL PSMA PET scanning in patients undergoing post-prostatectomy radiotherapy, with early biochemical response outcomes.

SV2A PET imaging is a non-invasive marker for the detection of spinal damages in experimental models of spinal cord injury.

Proceedings: PET Drugs: A Workshop on Inspections Management and Regulatory Considerations.

Analysis of short term and stable DNA damage in patients with differentiated thyroid cancer treated with <sup>131</sup>I in hypothyroidism or with rhTSH for remnant ablation.

Substitution of L-Trp by α-methyl-L-Trp in <sup>177</sup>Lu-RM2 results in <sup>177</sup>Lu-AMTG, a high affinity GRPR ligand with improved in vivo stability.

Synthesis and Preclinical Evaluation of <sup>177</sup>Lu-labeled Radiohybrid PSMA Ligands (rhPSMAs) for Endoradiotherapy of Prostate Cancer.

Interrogating glioma-associated microglia/macrophage dynamics under CSF-1R therapy with multi-tracer in vivo PET/MR imaging.

Evaluation of Data-Driven Rigid Motion Correction in Clinical Brain PET Imaging.

In vivo evaluation of six analogs of <sup>11</sup>C-ER176 as candidate <sup>18</sup>F-labeled radioligands for translocator protein 18 kDa (TSPO).

Positron emission tomography imaging of system xC¯ in immune cells for assessment of disease activity in mice and patients with inflammatory bowel disease.

Assessing reactive astrogliosis with <sup>18</sup>F-SMBT-1 across the Alzheimer's disease spectrum.

<sup>18</sup>F-PFPN PET: a new and attractive imaging modality for patients with malignant melanoma.

Molecular imaging of Neuroendocrine Prostate Cancer by targeting Delta-like Ligand 3.

Prospective phase II trial of prognostication by <sup>68</sup>Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy.

The impact of semi-automatic segmentation methods on metabolic tumor volume, intensity and dissemination radiomics in <sup>18</sup>F-FDG PET scans of patients with classical Hodgkin lymphoma.

Short-term colony stimulating factor-1 receptor inhibition-induced repopulation after stroke assessed by longitudinal 18F-DPA-714 PET imaging.

Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.

SIR-Spheres® activity measurements reveal systematic miscalibration.

Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.

CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

Fluorescent molecular imaging can improve intraoperative sentinel margin detection in oral squamous cell carcinoma.